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Introduction
In people, peripheral nerve sheath tumours (PNSTs) are a 
group of neoplasms that arise from Schwann cells, perineu-
rial cells and intraneuronal fibroblasts. Depending on their 
cell of origin, PNSTs can be further divided into schwan-
noma, neurofibroma and malignant PNSTs, respectively. 
According to the most recent edition of the World Health 
Organization’s International Classification of Tumors of 
Domestic Animals, PNSTs are, in veterinary medicine, 
divided into only benign and malignant variants because 
of their uncertain histogenenesis.1 PNSTs can be difficult to 
differentiate histologically from other spindle-cell tumours 
such as perivascular wall tumours and fibrosarcomas, and 
immunohistochemistry is often required to substantiate 
the diagnosis. The most common immunohistochemical 
marker used to support the morphological diagnosis of 
PNSTs is S100, which is expressed in up to 100% of cases.2
A recent retrospective study described pathological 
and clinical characteristics of 59 PNSTs in 53 cats.2 There 
were 43 benign PNSTs and 16 malignant PNSTs. The 
overall recurrence rate in the study was 23% (13/57). 
The recurrence rate for benign PNSTs was 15% (6/41); none 
of the tumours removed with clear margins recurred 
(19/19), while recurrence was seen in 27% (6/22) of the 
incompletely removed tumours. Between benign PNSTs, 
only one involved the lower eyelid and the tumour recurred 
after incomplete excision; another three were completely 
removed from the periocular skin, and none of them 
Marginal resection and adjuvant 
strontium plesiotherapy in the 
management of feline eyelid 
malignant peripheral nerve sheath 
tumours: two cases
Davide Berlato1, Ana Rita Serras1,*, Marian Matas Riera2,†  
and Roberta Rasotto3,‡
Abstract
Case series summary Two cats with a marginally resected eyelid malignant peripheral nerve sheath tumour were 
treated with adjuvant strontium plesiotherapy a few weeks after surgery. The dose applied in both cases was 
200 Gy to the surface, in five fractions, on a Monday–Wednesday–Friday basis. The treatment aimed to achieve 
a clinical margin of approximately 1 cm around the surgical scar and multiple application fields were required to 
cover such an area. Local recurrence was not seen in either case after 1330 and 645 days, respectively.
Relevance and novel information The majority of periocular malignant peripheral nerve sheath tumours reported in 
the literature recur after surgery. In the two cases described in this report the combination of surgery and adjuvant 
plesiotherapy has been able to provide good local control with minimal toxicity. This multimodal approach could be 
considered as an alternative to aggressive surgery such as enucleation or exenteration.
Accepted: 23 September 2016
1 Oncology Unit, Animal Heath Trust, Newmarket, UK
2 Ophthalmology Unit, Animal Heath Trust, Newmarket, UK
3 Diagnostic Laboratory Services, Animal Heath Trust,  
Newmarket, UK
* Current address: Hospital Veterinario de Berna, Lisbon, Portugal
† Current address: Royal Veterinary College, University of London, 
Hatfield, UK
‡ Current address: Dick White Referrals, Six Mile Bottom, UK
Corresponding author:
Davide Berlato, Dip ECVIM-CA (Onc), MSc (Clin Onc), PhD, 
MRCVS, Animal Health Trust, Lanwades Park, Kentford, 
Newmarket CB8 7UU, UK 
Email: davide.berlato@aht.org.uk
674863 JOR0010.1177/2055116916674863Journal of Feline Medicine and Surgery Open ReportsBerlato et al
research-article2016
Case Series
2 Journal of Feline Medicine and Surgery Open Reports 
recurred. The recurrence rate of malignant PNSTs was 44% 
(7/16); none of the tumours removed with clear margins 
recurred (6/6), while recurrence was seen in 70% (7/10) 
of the tumours removed with incomplete margin. Of 
the malignant PNSTs there was one tumour involving 
the upper eyelid and the tumour recurred after incomplete 
excision.
In another recent retrospective series describing 43 
feline eyelid tumours submitted to a single pathology 
laboratory, there were three PNSTs involving the eyelid.3 
In this study PNSTs were not classified as benign or 
malignant and margins of excision were not reported. 
All three eyelid PNSTs recurred after surgical excision.
A recent case series described presentation and out-
come of cutaneous periocular PNSTs in six cats.4 As 
in the previous study, PNSTs were not divided into 
benign and malignant and margin of excision were not 
described. All six tumours recurred, on average, three 
times after conservative surgical excision. After multi-
ple conservative surgeries, four of these cats underwent 
exenteration or enucleation as a curative-intent proce-
dure; none of the cats undergoing aggressive surgery 
presented tumour recurrence.
Radical or wide surgical resection or debulking sur-
gery followed by adjuvant radiotherapy is considered 
the treatment of choice for the management of soft tissue 
sarcomas in cats and dogs.5 However, adjuvant irradia-
tion of the periocular area with external beam radiother-
apy using curative-intent doses (>45 Gy) is limited by 
the risk of incurring in severe toxicity. Side effects 
reported in this location include dermatitis, conjunctivi-
tis, keratitis, iritis or chronic complications such as 
chronic keratoconjunctivitis sicca, corneal ulceration, 
secondary uveitis, chronic conjunctivitis, cataract forma-
tion, radiation retinopathy and optic neuropathy.6–9
Strontium plesiotherapy consists of the direct 
application of the radioactive source to the tumour sur-
face. Strontium 90 undergoes beta (β)–decay emitting 
β-particles, which are characterized by limited penetra-
tion ability into the irradiated tissue (2–3 mm). The shal-
low penetration is the main attraction of this treatment 
because it allows applying a large dose of radiation to 
the surface without affecting the deeper tissue. Strontium 
plesiotherapy has been successfully used in the treat-
ment of various periocular tumours in cats and dogs; for 
example, feline mast cell tumours,10,11 canine limbal mel-
anoma12 and canine limbal hemangiosarcomas.13
Herein, we present the use of conservative surgery fol-
lowed by adjuvant strontium plesiotherapy in the treat-
ment of two cases of malignant feline PNSTs involving the 
eyelid. Histopathology and immunohistochemistry in both 
cases were reviewed by a board-certified pathologist (RR).
Case series description
Case 1
A 11-year-old, female, neutered, domestic longhair cat 
was presented to the Ophthalmology Unit with a 4 mm 
mass on the left lower eyelid (Figure 1a). Cytology 
showed a spindle cell neoplastic population with severe 
nuclear atypia and occasional multinucleated cells. 
Staging including thoracic radiographs and abdominal 
ultrasound showed no evidence of metastatic disease.
Treatment options, including aggressive surgery or 
more conservative surgery followed by strontium plesi-
otherapy, were discussed with the owners and they 
elected for the more conservative approach. A wedge 
resection of the mass with double layer closure was per-
formed, leaving a relatively tight lower eyelid (Figure 1b), 
but no functional problems.
Histology revealed a poorly demarcated neoplastic 
proliferation of spindle cells expanding the eyelid der-
mis and arranged in bundles with occasional nuclear 
palisading. These cells displayed moderate anisocytosis 
and marked anisokaryosis. Multinucleation was occa-
sionally evident. Mitoses were 10 in 10 high-powered 
fields (HPFs). A histological diagnosis of soft tissue 
sarcoma, most likely a malignant PNST, was made. 
Immunohistochemistry showed that the neoplastic cells 
were positive for S100, confirming the diagnosis of malig-
nant PNST. The margin of excision was narrow (2 mm).
Strontium plesiotherapy was started 20 days after 
surgery. The treatment was delivered on a Monday–
Wednesday–Friday basis for five fractions to a total 
surface dose of 200 Gy. Each fraction consisted of five 
contiguous application fields to obtain a clinical margin 
of approximately 1 cm around the scar. The globe was 
protected from the radiation field using a Jaeger lid plate. 
No acute side effects developed during the treatment and 
the cat was discharged without any medication.
At re-examination 5 weeks later the owner reported 
no side effect apart from radiation-induced localized alo-
pecia (Figure 1c). The left eye was comfortable, with no 
evidence of ophthalmic abnormalities. Eyelid function 
and tear production were normal. Alopecia was still pre-
sent at the second re-examination 6 months later, but the 
remainder of the ophthalmological examination was 
unremarkable.
After collapsing, the cat was presented to the referring 
vet after 1330 days and the owner elected for euthanasia 
without any further investigations. At the time of the con-
sultation there was no evidence of local recurrence. The 
owner did not allow a post-mortem examination.
Case 2
A 5-year-old, female, neutered, domestic shorthair cat 
was referred to the Oncology Unit after incomplete 
excision of a 7 mm mass from the lateral aspect of 
the left lower eyelid. A blepharoplasty had been per-
formed to resect the mass, but information about the 
specific surgical technique used was not available upon 
referral.
Histology revealed a poorly demarcated spindle cell 
proliferation expanding the eyelid dermis with cells 
organized in bundles and admixed with oedematous 
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fibrillar matrix. Anisocytosis and anisokaryosis were 
moderate and mitoses were 2 in 10 HPFs. Small areas of 
necrosis were noted scattered throughout the tumour. 
The tumour was initially diagnosed as incompletely 
excised soft tissue sarcoma and subsequent immu-
nostaining for S-100 allowed a final diagnosis of malig-
nant PNST.
Revision surgery using a more aggressive approach 
or adjuvant plesiotherapy was discussed with the 
owners, and they elected for the more conservative 
approach.
Strontium plesiotherapy was started 33 days after 
surgery. The treatment was delivered on a Monday–
Wednesday–Friday basis for five fractions to a total sur-
face dose of 200 Gy. Each fraction consisted of six 
contiguous application fields providing a clinical margin 
of approximately 1 cm around the scar. During the treat-
ment the globe was protected using a plastic Jaeger lid 
Figure 1 Case 1: malignant peripheral nerve sheath tumour of the left lower eyelid (a) before and (b) after surgery.  
(c) Alopecia 5 weeks after the end of strontium plesiotherapy. Case 2: (d) plastic Jaeger lid plate in place to protect the eye 
during strontium plesiotherapy. (e) Cutaneous acute moist dermatitis 2 weeks after treatment, (f) followed by leukotrichia  
after a few months.
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plate (Figure 1d). At the end of the radiation course there 
was mild erythema in the irradiated area. Meloxicam 
was prescribed for 3 weeks as an anti-inflammatory and 
analgesic. A few days after the end of the radiotherapy 
moist desquamation developed (Veterinary Radiation 
Therapy Oncology Group grade 2 skin acute toxicity;9 
Figure 1e).
At re-examination 3 weeks later, the dermatitis was 
completely resolved, but the irradiated area was com-
pletely alopecic. At re-examination after 6 months, the 
irradiated area presented diffuse leukotrichia (Figure 1f), 
but there was no evidence of chronic ocular toxicity.
At the time of writing, 645 days after the end of the 
radiotherapy, the cat is still well and there is no evidence 
of tumour recurrence.
Discussion
Marginal resection followed by strontium plesiother-
apy was able to provide good local control in the two 
cases presented herein without performing aggressive 
surgery such as enucleation or exenteration. This was 
an extremely promising result considering that 11/14 
periocular PNSTs reported in the literature recurred 
after surgical excision.2–4
The dose of radiation prescribed in these two 
cases was 200 Gy to the surface or 50 Gy at a depth of 
2 mm,14 which is comparable with the total dose 
commonly prescribed as adjuvant treatment in cats 
with injection-site sarcoma treated with external beam 
radiotherapy.15
Compared with external beam radiotherapy, strontium 
plesiotherapy can be used to treat small areas (2–8 cm2) 
because only a limited number of contiguous fields can 
be successfully applied to an area. Both tumours pre-
sented in this report underwent surgery when their size 
was still small (4 and 7 mm, respectively), leaving a sur-
gical scar smaller than 1 cm. A margin of approximately 
1 cm around the scar was applied to define the treatment 
area, but this decision was driven by the practicality of 
the treatment, as specific data are not available in the lit-
erature. When planning external beam radiotherapy as 
adjuvant treatment of injection-site sarcomas a margin of 
3 cm around the surgical scar is commonly applied 
because of their tendency to infiltrate along the fascial 
planes.15,16 In the two cases presented in this series, we 
applied a narrower margin because non-injection site 
sarcomas are less biologically aggressive and infiltrative 
than injection-site sarcomas.17
Acute and long-term side effects associated with the 
treatment were limited to the skin and very mild. At re-
examination at 6 months there was no evidence of ocular 
toxicity such as cataract. In this sense we think that pro-
tecting the eye with a plastic Jaeger lid plate provided 
further attenuation to the already weak deep radiation 
dose.
Conclusions
Excisional globe-sparing surgery of small periocular 
PNSTs followed by adjuvant plesiotherapy may be a 
valid alternative to enucleation or exenteration. A larger 
number of cases would be necessary to further support 
the positive outcome seen in these cases.
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